NASDAQ:RWLK - Rewalk Robotics Stock Price, Forecast & News

Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

Rewalk Robotics Ltd (NASDAQ:RWLK) issued its quarterly earnings results on Thursday, February, 20th. The medical device company reported ($0.49) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.13. The medical device company earned $1.18 million during the quarter, compared to the consensus estimate of $2.35 million. Rewalk Robotics had a negative return on equity of 139.52% and a negative net margin of 319.13%. View Rewalk Robotics' Earnings History.

Rewalk Robotics is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Rewalk Robotics.

1 brokers have issued 1-year target prices for Rewalk Robotics' shares. Their forecasts range from $3.50 to $3.50. On average, they expect Rewalk Robotics' stock price to reach $3.50 in the next year. This suggests a possible upside of 325.8% from the stock's current price. View Analyst Price Targets for Rewalk Robotics.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rewalk Robotics.

Press coverage about RWLK stock has trended negative on Saturday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Rewalk Robotics earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave news coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Rewalk Robotics.

Rewalk Robotics saw a decrease in short interest in January. As of January 31st, there was short interest totalling 441,700 shares, a decrease of 5.6% from the January 15th total of 467,700 shares. Based on an average trading volume of 113,000 shares, the days-to-cover ratio is presently 3.9 days. Currently, 6.5% of the company's stock are short sold. View Rewalk Robotics' Current Options Chain.

Some companies that are related to Rewalk Robotics include Bionik Laboratories (BNKL), NanoVibronix (NAOV), Allied Healthcare Products (AHPI), Ocugen (OCGN), Precision Therapeutics (POAI) and Avitar (AVTI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Rewalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners, L.P (CLMT), Two Harbors Investment (TWO), Novocure (NVCR), Blackrock Capital Investment (BKCC), Viper Energy Partners (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Roper Technologies (ROP).

Rewalk Robotics' stock is owned by many different of institutional and retail investors. Top institutional investors include FNY Investment Advisers LLC (3.15%), Advisor Group Inc. (3.10%) and Virtu Financial LLC (0.29%). Company insiders that own Rewalk Robotics stock include Lawrence J Jasinski and Ofir Koren. View Institutional Ownership Trends for Rewalk Robotics.

RWLK stock was acquired by a variety of institutional investors in the last quarter, including Advisor Group Inc., Virtu Financial LLC and FNY Investment Advisers LLC. View Insider Buying and Selling for Rewalk Robotics.

Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RWLK stock can currently be purchased for approximately $0.82.

Rewalk Robotics has a market capitalization of $11.41 million and generates $4.87 million in revenue each year. The medical device company earns $-21,670,000.00 in net income (profit) each year or ($2.70) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe.View Additional Information About Rewalk Robotics.

The official website for Rewalk Robotics is http://www.rewalk.com/.

Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]